Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Pooled analyses after long-term follow-up in KEYNOTE-012.Ranee Mehra, Robert I. Haddad, Tanguy Y. Seiwert et al.|Journal of Clinical Oncology|2016Cited by 45